Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency

Journal of Neuroimmunology

Volumn 192, Issue 1-2, 2007, Pages 124-133

  Frausto, Ricardo F ^a   Crocker, Stephen J ^a   Eam, Boreth ^a   Whitmire, Jason K ^a   Whitton, J Lindsay ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CD4+ T cell; CD8+ T cell; EAE; Immunoproteasome

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEASOME;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; INFLAMMATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; TIME FACTORS;

EID: 36849074828     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.09.024     Document Type: Article

References (76)

1. Abdul-Majid K.B., Wefer J., Stadelmann C., Stefferl A., Lassmann H., Olsson T., and Harris R.A. Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4-/- and CD8-/-DBA/1 mice defines qualitative roles of different T cell subsets. J. Neuroimmunol. 141 (2003) 10-19
2. + T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192 (2000) 393-404
3. Barnett L.A., Whitton J.L., Wada Y., and Fujinami R.S. Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J. Neuroimmunol. 44 (1993) 15-25
4. Barnett L.A., Whitton J.L., Wang L.Y., and Fujinami R.S. Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis. J. Neuroimmunol. 64 (1996) 163-173
5. Barry M.A., Lai W.C., and Johnston S.A. Protection against mycoplasma infection using expression-library immunization. Nature 377 (1995) 632-635
6. Booss J., Esiri M.M., Tourtellotte W.W., and Mason D.Y. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62 (1983) 219-232
7. Crocker S.J., Whitmire J.K., Frausto R.F., Chertboonmuang P., Soloway P.D., Whitton J.L., and Campbell I.L. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. Am. J. Pathol. 169 (2006) 2104-2116
8. + T-cells in the development of MS. Neurol. Res. 28 (2006) 245-249
9. Dressel A., Chin J.L., Sette A., Gausling R., Hollsberg P., and Hafler D.A. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands. J. Immunol. 159 (1997) 4943-4951
10. Driscoll J., Brown M.G., Finley D., and Monaco J.J. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365 (1993) 262-264
11. Feuer R., Mena I., Pagarigan R.R., Harkins S., Hassett D.E., and Whitton J.L. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am. J. Pathol. 163 (2003) 1379-1393
12. + T cell responses during experimental autoimmune encephalomyelitis. Eur. J. Immunol 35 (2005) 76-85
13. + T cell activation and expansion by CD43. Cell. Immunol. 240 (2006) 53-61
14. Foster B., Prussin C., Liu F., Whitmire J.K., and Whitton J.L. Detection of intracellular cytokines by flow cytometry. In: Coligan J.E., Kruisbeek A.M., Marguiles D.H., Shevach E.M., and Strober W. (Eds). Current Protocols in Immunology (2007), John Wiley & Sons
15. Gold R., Linington C., and Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (2006) 1953-1971
16. Hauser S.L., Aubert C., Burks J.S., Kerr C., Lyon-Caen O., de T.G., and Brahic M. Analysis of human T-lymphotrophic virus sequences in multiple sclerosis tissue. Nature 322 (1986) 176-177
17. Hauser S.L., Bhan A.K., Gilles F., Kemp M., Kerr C., and Weiner H.L. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19 (1986) 578-587
18. Hoftberger R., boul-Enein F., Brueck W., Lucchinetti C., Rodriguez M., Schmidbauer M., Jellinger K., and Lassmann H. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 14 (2004) 43-50
19. + T cells in a model for multiple sclerosis. J. Exp. Med. 194 (2001) 669-676
20. Ito D., Imai Y., Ohsawa K., Nakajima K., Fukuuchi Y., and Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res. Mol. Brain Res. 57 (1998) 1-9
21. + T cells. Ann. N.Y. Acad. Sci. 1103, 157-166. (2007)
22. + T cells in murine experimental allergic encephalomyelitis. Science 256 (1992) 1213-1215
23. + T cells in early multiple sclerosis. Clin. Immunol. 123 (2007) 105-113
24. Joly E., and Oldstone M.B.A. Neuronal cells are deficient in loading peptides onto MHC class I molecules. Neuron 8 (1992) 1185-1190
25. Joly E., Mucke L., and Oldstone M.B.A. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253 (1991) 1283-1285
26. Jurewicz A., Biddison W.E., and Antel J.P. MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J. Immunol. 160 (1998) 3056-3059
27. Koh D.R., Fung-Leung W.P., Ho A., Gray D., cha-Orbea H., and Mak T.W. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 256 (1992) 1210-1213
28. Lehmann P.V., Forsthuber T., Miller A., and Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358 (1992) 155-157
29. Lehmann P.V., Sercarz E.E., Forsthuber T., Dayan C.M., and Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 14 (1993) 203-208
30. Liblau R., van Endert P.M., Sandberg-Wollheim M., Patel S.D., Lopez M.T., Land S., Fugger L., and McDevitt H.O. Antigen processing gene polymorphisms in HLA-DR2 multiple sclerosis. Neurology 43 (1993) 1192-1197
31. Lincoln M.R., Montpetit A., Cader M.Z., Saarela J., Dyment D.A., Tiislar M., Ferretti V., Tienari P.J., Sadovnick A.D., Peltonen L., Ebers G.C., and Hudson T.J. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat. Genet. 37 (2005) 1108-1112
32. Lindsey J.W., Hodgkinson S., Mehta R., Mitchell D., Enzmann D., and Steinman L. Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis. Ann. Neurol. 36 (1994) 183-189
33. + T cells during primary and secondary viral infections. J. Immunol. 174 (2005) 5936-5940
34. Maksymowych W.P., and Russell A.S. Polymorphism in the LMP2 gene influences the relative risk for acute anterior uveitis in unselected patients with ankylosing spondylitis. Clin. Invest. Med. 18 (1995) 42-46
35. Maksymowych W.P., Wessler A., Schmitt-Egenolf M., Suarez-Almazor M., Ritzel G., von Borstel R.C., Pazderka F., and Russell A.S. Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J. Rheumatol. 21 (1994) 665-669
36. Maksymowych W.P., Suarez-Almazor M., Chou C.T., and Russell A.S. Polymorphism in the LMP2 gene influences susceptibility to extraspinal disease in HLA-B27 positive individuals with ankylosing spondylitis. Ann. Rheum. Dis. 54 (1995) 321-324
37. Maksymowych W.P., Tao S., Vaile J., Suarez-Almazor M., Ramos-Remus C., and Russell A.S. LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis. J. Rheumatol. 27 (2000) 183-189
38. McCallum K., Esiri M.M., Tourtellotte W.W., and Booss J. T cell subsets in multiple Gradients at plaque borders and differences in nonplaque regions. Brain 110 Pt 5 (1987) 1297-1308
39. Medana I., Martinic M.A., Wekerle H., and Neumann H. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am. J. Pathol. 159 (2001) 809-815
40. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch R.L., Neville K.L., Katz-Levy Y., Carrizosa A., and Kim B.S. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3 (1997) 1133-1136
41. Miller S.D., Katz-Levy Y., Neville K.L., and Vanderlugt C.L. Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler's virus infection of the central nervous system. Adv. Virus Res. 56 (2001) 199-217
42. Monaco J.J. A molecular model of MHC class-I-restricted antigen processing. Immunol. Today 13 (1992) 173-179
43. Montero E., Nussbaum G., Kaye J.F., Perez R., Lage A., Ben-Nun A., and Cohen I.R. Regulation of experimental autoimmune encephalomyelitis by CD4(+), CD25(+) and CD8(+) T cells: analysis using depleting antibodies. J. Autoimmun. 23 (2004) 1-7
44. Neumann H., Cavalie A., Jenne D.E., and Wekerle H. Induction of MHC class I genes in neurons. Science 269 (1995) 549-552
45. Neumann H., Schmidt H., Cavalie A., Jenne D., and Wekerle H. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-g and tumor necrosis factor (TNF)-a. J. Exp. Med. 185 (1997) 305-316
46. Neumann H., Medana I.M., Bauer J., and Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25 (2002) 313-319
47. Niedermann G. Immunological functions of the proteasome. Curr. Top. Microbiol. Immunol. 268 (2002) 91-136
48. Pryhuber K.G., Murray K.J., Donnelly P., Passo M.H., Maksymowych W.P., Glass D.N., Giannini E.H., and Colbert R.A. Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis. J. Rheumatol. 23 (1996) 747-752
49. Rodriguez F., Zhang J., and Whitton J.L. DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction, and antiviral protection, but abrogates antibody induction. J. Virol. 71 (1997) 8497-8503
50. Rodriguez F., An L.L., Harkins S., Zhang J., Yokoyama M., Widera G., Fuller J.T., Kincaid C., Campbell I.L., and Whitton J.L. DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J. Virol. 72 (1998) 5174-5181
51. + cytotoxic lymphocytes. J. Neuroimmunol. 42 (1993) 105-111
52. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P.N., and Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13 (1996) 464-468
53. Sawcer S., Ban M., Maranian M., Yeo T.W., Compston A., Kirby A., Daly M.J., De Jager P.L., Walsh E., Lander E.S., Rioux J.D., Hafler D.A., Ivinson A., Rimmler J., Gregory S.G., Schmidt S., Pericak-Vance M.A., Akesson E., Hillert J., Datta P., Oturai A., Ryder L.P., Harbo H.F., Spurkland A., Myhr K.M., Laaksonen M., Booth D., Heard R., Stewart G., Lincoln R., Barcellos L.F., Hauser S.L., Oksenberg J.R., Kenealy S.J., and Haines J.L. A high-density screen for linkage in multiple sclerosis. Am. J. Hum.Genet. 77 (2005) 454-467
54. + phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destruction. Am. J. Pathol. 163 (2003) 1517-1524
55. Schubert U., Anton L.C., Gibbs J., Norbury C.C., Yewdell J.W., and Bennink J.R. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404 (2000) 770-774
56. + T cells. Nature 401 (1999) 76-79
57. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67 (1998) 227-264
58. Steinman L. Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J. Exp. Med. 194 (2001) F27-F30
59. Steinman L., and Zamvil S.S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60 (2006) 12-21
60. Sun D., Qin Y., Chluba J., Epplen J.T., and Wekerle H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 332 (1988) 843-845
61. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166 (2001) 7579-7587
62. + MOG-specific T cells on oligomeric MHC class I molecules. Int. Immunol. 15 (2003) 261-268
63. Tanaka K., and Kasahara M. The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. Immunol. Rev. 163 (1998) 161-176
64. Theil D.J., Tsunoda I., Rodriguez F., Whitton J.L., and Fujinami R.S. Viruses can silently prime for and trigger central nervous system autoimmune disease. J. Neurovirol. 7 (2001) 1-8
65. The International Multiple Sclerosis Genetics Consortium, 2007. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357, 851-862.
66. Tobery T.W., and Siliciano R.F. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J. Exp. Med. 185 (1997) 909-920
67. Traugott U., Reinherz E.L., and Raine C.S. Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J. Neuroimmunol. 4 (1983) 201-221
68. + T-cell responses to human myelin protein-derived peptides. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 10859-10863
69. Vanderlugt C.L., Begolka W.S., Neville K.L., Katz-Levy Y., Howard L.M., Eagar T.N., Bluestone J.A., and Miller S.D. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol. Rev. 164 (1998) 63-72
70. van Endert P.M., Liblau R.S., Patel S.D., Fugger L., Lopez T., Pociot F., Nerup J., and McDevitt H.O. Major histocompatibility complex-encoded antigen processing gene polymorphism in IDDM. Diabetes 43 (1994) 110-117
71. van Kaer L., Ashton-Rickardt P.G., Eichelberger M., Gaczynska M., Nagashima K., Rock K.L., Goldberg A.L., Doherty P.C., and Tonegawa S. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1 (1994) 533-541
72. van Oosten B.W., Lai M., Hodgkinson S., Barkhof F., Miller D.H., Moseley I.F., Thompson A.J., Rudge P., McDougall A., McLeod J.G., Ader H.J., and Polman C.H. Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology 49 (1997) 351-357
73. Wang L.Y., Theil D.J., Whitton J.L., and Fujinami R.S. Infection with a recombinant vaccinia virus encoding myelin proteolipid protein causes suppression of chronic relapsing-remitting experimental allergic encephalomyelitis. J. Neuroimmunol. 96 (1999) 148-157
74. + T cells to increase their abundance during virus infection. J. Exp. Med. 201 (2005) 1053-1059
75. Yaouanq J., Semana G., Eichenbaum S., Quelvennec E., Roth M.P., Clanet M., Edan G., and Clerget-Darpoux F. Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS. Science 276 (1997) 664-665
76. Yeo T.W., De Jager P.L., Gregory S.G., Barcellos L.F., Walton A., Goris A., Fenoglio C., Ban M., Taylor C.J., Goodman R.S., Walsh E., Wolfish C.S., Horton R., Traherne J., Beck S., Trowsdale J., Caillier S.J., Ivinson A.J., Green T., Pobywajlo S., Lander E.S., Pericak-Vance M.A., Haines J.L., Daly M.J., Oksenberg J.R., Hauser S.L., Compston A., Hafler D.A., Rioux J.D., and Sawcer S. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann. Neurol. 61 (2007) 228-236